FOUNDERS EDITION NOW LIVE
THE SCIENCE
Every active in a can of Void is dosed from published human research. Here's what each one does, how much we use, and the papers behind it.
PER 12 OZ CAN
Blocks adenosine, the brain's drowsiness signal. 150mg alone improved vigilance and cut mental fatigue in a 22-person crossover trial (Haskell 2008). One can is under half the 400mg daily guideline.
What it does. Adenosine builds up in the brain while you're awake and signals drowsiness. Caffeine blocks its receptors, which keeps neurons firing and indirectly raises dopamine and norepinephrine signalling. The felt result is better alertness, vigilance and reaction time.
What the research shows. The International Society of Sports Nutrition's 2021 position stand concludes caffeine improves attention and vigilance in most people, with effects starting at roughly 2mg per kg of body weight. A 2016 review in Neuroscience & Biobehavioral Reviews found low-to-moderate doses (about 40β300mg) reliably improve vigilance, attention and reaction time, especially when you're tired. In a 22-person crossover trial, 150mg of caffeine β the exact amount in a can of Void β improved digit-vigilance reaction time and rapid visual processing accuracy, and reduced self-rated mental fatigue.
Why 150mg. For a 75kg adult, 150mg is about 2mg/kg: the low end of the effective range, roughly a strong cup of coffee. It's enough to sharpen attention without pushing heart rate and jitters, and it leaves room in the day. The FDA considers up to 400mg a day generally safe for healthy adults; one can is 37.5% of that.
Timing. Effects begin in 15β30 minutes, peak between 30 and 120 minutes, and the half-life is 4β6 hours β so keep it out of the 6 hours before bed.
REFERENCES
The amino acid in green tea. A 2026 meta-analysis of 31 trials found a single 200mg dose sharpened reaction time and eased stress. Paired with caffeine it improves attention-switching and cuts the jitters (Haskell 2008, Giesbrecht 2010).
What it does. Theanine crosses the bloodβbrain barrier and increases alpha-band brain activity β the frequency associated with relaxed alertness. It modestly raises GABA, glycine and dopamine and blunts the body's sympathetic stress response (heart rate, salivary IgA). Unlike a sedative, it promotes calm without drowsiness.
What the research shows. A 2026 meta-analysis in Molecular Psychiatry pooled 31 randomised trials (1,168 people). A single 200mg dose taken 30β60 minutes before testing improved choice reaction time (effect size 0.51) and modestly reduced acute stress; no serious adverse events were reported. In a 4-week trial, 200mg a day improved trait anxiety, sleep quality, verbal fluency and executive function versus placebo. Under a mental-arithmetic stressor, 200mg blunted the rise in heart rate and stress markers.
Why it's paired with caffeine. This is the best-replicated pairing in the formula. 150mg caffeine plus 250mg theanine β almost exactly Void's ratio β produced faster reaction times, better accuracy, higher alertness and lower headache and fatigue than placebo. Lower doses (40β50mg caffeine with 97β100mg theanine) improved task-switching accuracy and reduced distractibility compared with caffeine alone, with only a ~3 mmHg rise in systolic blood pressure.
Why 200mg. 200mg is the single most-studied dose in the literature and matches Void exactly. Onset is 30β60 minutes; the alpha-wave effect lasts 2β3 hours.
REFERENCES
A form of choline that crosses into the brain to make acetylcholine, the attention-and-learning neurotransmitter. 400mg a day raised motivation scores versus placebo over two weeks (Tamura 2021).
What it does. Alpha-GPC (L-alpha-glycerylphosphorylcholine) is a phospholipid-bound form of choline that crosses the bloodβbrain barrier and supplies the raw material for acetylcholine β the neurotransmitter of attention, learning and muscle activation. 400mg delivers roughly 160mg of choline, about 29% of the adult Adequate Intake.
What the research shows. In a 2021 placebo-controlled trial, 39 healthy adults took 400mg a day β Void's exact dose β for two weeks; motivation scores measured in the evening were significantly higher than placebo, with no adverse events across a 12-month follow-up. A small pilot in resistance-trained men found 600mg taken 90 minutes before exercise raised peak bench-press force 14% versus placebo. A 2017 randomised trial compared 250mg and 500mg daily on strength, reaction time and mental arithmetic.
Honest framing. Trials in healthy adults are small and several are industry-funded; the largest body of evidence is in clinical populations at higher doses, which we cite only for mechanism, not as a claim. Void's 400mg sits inside the 250β600mg range used in the healthy-adult studies.
Timing. Plasma choline rises within 1β2 hours; pre-exercise studies dosed 60β90 minutes ahead.
REFERENCES
The building block of dopamine and norepinephrine. Research shows it helps working memory hold up under stress and long hours β exactly when a deadline is on (Jongkees 2015 review).
What it does. Tyrosine is the amino-acid precursor of dopamine and norepinephrine. Under acute stress, noise, cold or sleep loss these catecholamines are used faster than they're replenished; extra tyrosine helps sustain synthesis so working memory and cognitive control hold up. In a rested, unstressed brain it does little β the enzyme that converts it is already saturated.
What the research shows. A 2015 systematic review in the Journal of Psychiatric Research concluded tyrosine effectively enhances cognitive performance in short-term stressful or cognitively demanding situations, with no benefit when the system isn't under load. In a 22-person trial, a 2g dose raised accuracy on a demanding 2-back working-memory task from 86.5% to 91.4%, with no effect on the easy version. Cadets given tyrosine during a one-week combat course performed better on memory and tracking tasks and had lower systolic blood pressure than placebo.
Honest framing. Most positive trials used 2g or more; military studies used 7β10g. Void's 1,000mg is below those acute doses, so we describe it as a meaningful amount of the catecholamine precursor rather than claiming the trial results. It's included because the use case β long, demanding sessions β is exactly where tyrosine has been shown to matter.
Safety. Well tolerated in short studies up to 12g a day. Talk to a clinician if you take MAO inhibitors, levodopa or thyroid medication.
REFERENCES
A traditional calming botanical. Its rosmarinic acid slows the breakdown of GABA. In beverage trials it lowered self-rated stress during a pressure task (Scholey 2014). We include it to keep the focus calm.
What it does. Lemon balm (Melissa officinalis) contains rosmarinic acid and triterpenes that inhibit GABA-transaminase, the enzyme that breaks down GABA β so the brain's main calming neurotransmitter lingers longer. Extracts also bind to acetylcholine receptors. In trials the net effect is increased self-rated calmness, and at some doses better attention accuracy.
What the research shows. In a 20-person crossover study, single doses of 300β900mg increased calmness (at 300 and 900mg) and improved attention accuracy (at 600mg). Before a laboratory stressor, 600mg blunted the negative-mood effects of stress; 300mg sped up mathematical processing. In two trials using lemon balm in a beverage β the closest match to a can β 300mg reduced state anxiety during a stress task. A 2024 review calls it a promising calming agent but notes trials are heterogeneous and more RCTs are needed.
Honest framing. The acute calming effects were seen at 300β600mg; Void's 200mg is below every dose tested in those trials. We include it as a traditional calming botanical that complements theanine, not as a standalone active with a proven effect at this dose.
Safety. Well tolerated; higher doses can be mildly sedating. Use caution with sedatives or thyroid medication.
REFERENCES
0β30 min caffeine absorbs, theanine lifts alpha waves Β· 30β120 peak focus, choline and tyrosine top up attention chemistry Β· 2β4 hr smooth taper, no sugar dip.
12-pack Β· 30% off your first box when you subscribe.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Study citations refer to the doses and populations tested; individual results vary.